Grove AI raised $4.9 million in a seed funding round led by A* to scale its team and redefine clinical trials with Agentic AI.
Grove AI raised $4.9 million in a seed funding round led by A* to scale its team and redefine clinical trials with Agentic AI.
01/07/25, 6:36 PM
Location
san franciscoMoney raised
$4.9 million
Industry
machine learning
artificial intelligence
biotechnology
health care
Round Type
seed
Investors
Upfront Ventures, Pear Vc, Life X Ventures, Afore Capital, A*
Grove AI announced a $4.9 million seed fundraise to enhance its clinical trial management platform. The investment will help the company create participant-centered ecosystems driven by real-time data.
Company Info
Location
san francisco, california, united states
Additional Info
Grove AI revolutionizes clinical trials with its AI-powered participant relationship management (PRM) platform, delivering actionable insights and accelerating critical trial processes. Grove empowers research organizations to streamline operations, engage participants, and accelerate life-saving therapies. With Grove, clinical trials shift from cumbersome, manual workflows to adaptive, data-driven ecosystems that operate at the speed of innovation—bringing life-saving treatments to patients faster than ever.